Citation Impact
Citing Papers
New approaches and procedures for cancer treatment: Current perspectives
2021 Standout
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
2015 Standout
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells
2012
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
Neutrophils at work
2014 Standout
Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma
2010
Advances in stem cell mobilization
2012
Molecular mechanisms of resistance and toxicity associated with platinating agents
2006 Standout
Current approaches in dendritic cell generation and future implications for cancer immunotherapy
2007
Pharmacokinetics of high-dose i.v. treosulfan in children undergoing treosulfan-based preparative regimen for allogeneic haematopoietic SCT
2008
Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer
2009
Nanocarriers for delivery of platinum anticancer drugs
2013
Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation
2007
Mobilization and collection of peripheral blood progenitor cells for transplantation
2005
Gemcitabine-induced hemolytic uremic syndrome in ovarian carcinoma
2007
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Toxicity of platinum compounds
2003
Minimizing Long-Term Tumor Burden: The Logic for Metronomic Chemotherapeutic Dosing and its Antiangiogenic Basis
2003
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Determination of treosulfan in plasma and urine by HPLC with refractometric detection; pharmacokinetic studies in children undergoing myeloablative treatment prior to haematopoietic stem cell transplantation
2006
Analysis of anticancer drugs: A review
2011 Standout
Doxil® — The first FDA-approved nano-drug: Lessons learned
2012 Standout
Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: Analysis from the GCIG CALYPSO relapsing ovarian cancer trial
2011
Idarucizumab for Dabigatran Reversal
2015 Standout
Gemcitabine-associated thrombotic thrombocytopenic purpura
2007
Cisplatin: The first metal based anticancer drug
2019 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
2010 Standout
Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab
2010
Is therapeutic plasma exchange indicated for patients with gemcitabine‐induced hemolytic uremic syndrome?
2009
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis
2007
Cancer of the Ovary
2004 Standout
Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation
2009 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
The side effects of platinum-based chemotherapy drugs: a review for chemists
2018 Standout
Recent major improvement in long-term survival of younger patients with multiple myeloma
2007
Epithelial Mesenchymal Transition in Tumor Metastasis
2018 Standout
Clinical Features of Hypersensitivity Reactions to Carboplatin
1999
Mechanisms of Cisplatin Nephrotoxicity
2010 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Conditioning regimens for hematopoietic cell transplantation: one size does not fit all
2014
Gemcitabine‐induced thrombotic microangiopathy
2013
Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Hematologic Malignancies After Dose-Escalated Treosulfan/Fludarabine Conditioning
2010
Indications for Imatinib Mesylate Therapy and Clinical Management
2004
Multiple Myeloma
2011 Standout
Isolated Tumor Cells in Bone Marrow Three Years after Diagnosis in Disease-Free Breast Cancer Patients Predict Unfavorable Clinical Outcome1
2004
Hematological Problems in Pediatric Intensive Care
2013 Standout
Works of Peter Bojko being referenced
Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution
2004
Survival of tumor cells in stem cell preparations and bone marrow of patients with high-risk or metastatic breast cancer after receiving dose-intensive or high-dose chemotherapy.
2001
Hypersensitivity reactions to carboplatin. Report of two patients, review of the literature, and discussion of diagnostic procedures and management
1994
Imatinib mesylate therapy in patients with gastrointestinal stromal tumors and impaired liver function
2002
Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patients
2003
Clinical phase I dose escalation and pharmacokinetic study of high-dose chemotherapy with treosulfan and autologous peripheral blood stem cell transplantation in patients with advanced malignancies.
2000
Thalidomide in combination with vincristine, epirubicin and dexamethasone (VED) for previously untreated patients with multiple myeloma
2004